CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 162 filers reported holding CARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,815,000 | +43.5% | 83,600 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,265,000 | +16.4% | 83,600 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $1,087,000 | -23.7% | 85,400 | +2.5% | 0.00% | 0.0% |
| Q2 2020 | $1,424,000 | +21.6% | 83,300 | -6.0% | 0.00% | 0.0% |
| Q1 2020 | $1,171,000 | -30.4% | 88,651 | -15.1% | 0.00% | -50.0% |
| Q4 2019 | $1,683,000 | -7.8% | 104,451 | +4.6% | 0.00% | 0.0% |
| Q3 2019 | $1,825,000 | -0.8% | 99,851 | +16.6% | 0.00% | 0.0% |
| Q2 2019 | $1,840,000 | +8.0% | 85,603 | -1.4% | 0.00% | 0.0% |
| Q1 2019 | $1,703,000 | +51.0% | 86,798 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,128,000 | -45.0% | 86,798 | +1.4% | 0.00% | -33.3% |
| Q3 2018 | $2,050,000 | +14.8% | 85,600 | -8.2% | 0.00% | +50.0% |
| Q2 2018 | $1,785,000 | +1.2% | 93,200 | -34.6% | 0.00% | -33.3% |
| Q1 2018 | $1,764,000 | +1.1% | 142,500 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $1,744,000 | -23.4% | 142,500 | -14.3% | 0.00% | -33.3% |
| Q3 2017 | $2,276,000 | +3.8% | 166,273 | +16.7% | 0.00% | -25.0% |
| Q2 2017 | $2,193,000 | -16.3% | 142,500 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,621,000 | +98.0% | 142,500 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $1,324,000 | +11.3% | 142,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,190,000 | +73.7% | 142,500 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $685,000 | -22.7% | 142,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $886,000 | -63.1% | 142,500 | 0.0% | 0.00% | -75.0% |
| Q4 2015 | $2,403,000 | +18.0% | 142,500 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $2,036,000 | +17.6% | 142,500 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,731,000 | +10.4% | 142,500 | 0.0% | 0.00% | +50.0% |
| Q1 2015 | $1,568,000 | 0.0% | 142,500 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,568,000 | +1766.7% | 142,500 | +1325.0% | 0.00% | – |
| Q3 2014 | $84,000 | -50.6% | 10,000 | 0.0% | 0.00% | – |
| Q2 2014 | $170,000 | -6.6% | 10,000 | 0.0% | 0.00% | – |
| Q1 2014 | $182,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |